GlaxoSmithkline Consumer Healthcare’s Q1 net rises 8%

Glaxosmithkline Consumer Healthcare Ltd. - (Amalgamated) | Consumer Food | FMCG | BSE: 500676 | NSE: GSKCONS

07 Aug 2014 Evaluate

GlaxoSmithkline Consumer Healthcare has reported results for first quarter ended June 30, 2014.

The company’s net profit has surged 8.47% at Rs 130.12 crore as compared to Rs 119.96 crore for the quarter ended June 30, 2013. Its total income has increased by 8.92% to Rs 1011.73 crore for the quarter under review from Rs 928.83 crore for the corresponding quarter of the previous year.

GlaxoSmithKline Consumer Healthcare is a subsidiary of GlaxoSmithKline plc of UK, a global science based healthcare company. GlaxoSmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks. It exports products to countries like Bangladesh, Myanmar, Sri Lanka, Middle East, Fiji, Mauritius, Nepal, Bhutan and many more.

Peers

Company Name	CMP
Nestle India	1337.60
Varun Beverages	431.45
Britannia Industries	4845.50
LT Foods	411.15
Hatsun Agro Product	1110.40
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.